ORGANOGENESIS HOLDINGS INC. - CLASS A

Organogenesis Expands Manufacturing Capacity to Support Future Growth

22 ноя 2024 16:05:00 Источник Nasdaq GlobeNewswire

Organogenesis Commends Final LCDs

15 ноя 2024 09:25:44 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results

12 ноя 2024 16:05:01 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock

12 ноя 2024 16:01:00 Источник Nasdaq GlobeNewswire

Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis

11 ноя 2024 17:05:00 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024

16 окт 2024 07:30:00 Источник Nasdaq GlobeNewswire

Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers

01 окт 2024 16:05:00 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September

04 сен 2024 16:05:00 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. Reports Second Quarter 2024 Financial Results

08 авг 2024 16:05:01 Источник Nasdaq GlobeNewswire

Organogenesis Shares ReNu® Program Update

08 авг 2024 16:04:00 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024

15 июл 2024 16:05:00 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference

06 июн 2024 16:05:00 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results

09 май 2024 16:05:00 Источник Nasdaq GlobeNewswire

Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis

02 май 2024 07:00:01 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024

16 апр 2024 07:30:00 Источник Nasdaq GlobeNewswire

Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case

03 апр 2024 07:30:00 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance

29 фев 2024 16:05:00 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

12 фев 2024 07:30:00 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024

08 фев 2024 16:05:00 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results

09 ноя 2023 16:05:00 Источник Nasdaq GlobeNewswire